Viramune (Nevirapine)
| Brand Name: |
Viramune |
| Generic Name: |
Nevirapine, NVP |
| Adult Single Dose: |
One 200-mg tablet (once a day) for
14 days then one 200-mg tablet (twice a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NNRTI |
The Basics
News
 A "New" Antiretroviral Option Quietly Enters the Market (April 25, 2011)
From Journal Watch
- FDA Approves Extended-Release Version of HIV Drug (April 6, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves Nevirapine XR (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Announces Approval of Once-Daily Form of Viramune (Nevirapine) (March 28, 2011)
From U.S. Food and Drug Administration
- Switching to Viramune Is Possible at Higher CD4s (February 1, 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- New Assistance Program Helps HIVers Pay for Viramune (October 7, 2009)
From The Body
- Summary of FDA Advisory on Nevirapine in Women With a CD4 Count Over 250 (February 28, 2005)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- FDA Public Health Advisory for Nevirapine (Viramune) (January 19, 2005)
From U.S. Food and Drug Administration
- Nevirapine Misinformation: Will It Kill? (December 31, 2004)
[Archived Article]
From AIDS Treatment News
- South Africa Drops Recommendation of Single-Dose Nevirapine Monotherapy for Pregnant Women (July 14, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Nevirapine Precautions Published (February 27, 2004)
[Archived Article]
New instructions provide information on who is most at risk for rare but serious liver-related side effects.
In AIDS Treatment News, from AIDS Treatment News
- Nevirapine-Based Fixed-Dose Combination Antiretrovirals in Resource-Limited Settings (May 2003)
[Archived Article]
Excerpted from HIV & AIDS Treatment in Practice.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Boehringer Ingelheim Pharmaceuticals Withdraws AIDS Drug Application (March 25, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Let Nevirapine Do What It Does Best (March 2002)
[Archived Article]
Why recent doubts about widespread use of the drug are unfounded.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- St. John's Wort Found to Lower Nevirapine Levels (March 2, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Severe Nevirapine Rash Found More Likely in Women Than Men (January 22, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Nevirapine Warning on Post-Exposure Prophylaxis (January 12, 2001)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Viramune May Cause Liver Damage (January 2001)
[Archived Article]
In Survival News, from AIDS Survival Project
- Sex Differences in Nevirapine Rash and Hepatitis (January 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Roxane Issues Strengthened Warning of Viramune-Related Liver Problems (December 15, 2000)
[Archived Article]
In STEP Ezine, from Seattle Treatment Education Project
- More Caution With Nevirapine (December 11, 2000)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Nevirapine (Viramune) Strengthens Warning on Liver, Skin Toxicities (November 17, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Nevirapine, Prednisone, and Rash (October 2000)
[Archived Article]
In Project Inform Perspective, from Project Inform
- Nevirapine (Viramune): European Warning (May 5, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half (July 16, 1999)
[Archived Article]
From AIDS Treatment News
|
|
Advertisement
|
Email
Glossary
